Patient
|
Age
|
Sex
|
Glucose (mg/dl)
|
Rx Treatments
|
Glucose (mg/dl)
|
Rx Treatments
|
Glucose (mg/dl)
|
---|
| | |
at Baseline
|
at Baseline
|
on GlucoMedix
|
on GlucoMedix
|
Reduction (Ave.)
|
S1
|
53
|
F
|
175–200
|
Glibenclamide, Met.
|
130–145
|
none
|
50
|
S2
|
50
|
F
|
180–200
|
Vildagliptin
|
110–130
|
none
|
70
|
R1
|
53
|
M
|
127
|
none
|
85–105
|
none + diet
|
32
|
| | | | |
100–120
|
none
|
17
|
O1
|
59
|
M
|
200–270
|
Glibenclamide, Met.
|
121
|
Glibenclamide, Met.
|
114
|
R2
|
54
|
M
|
130–165
|
none
|
78–116
|
none
|
50
|
R3
|
65
|
F
|
> 150
|
Insulin, Metformin
|
< 100
|
Insulin
|
> 50
|
| | | | |
< 140
|
Insulin (half dose)
|
> 10
|
- Abbreviations: Rx prescription drugs or biologics; Met. Metformin